The University of Navarra is hosting the congress proteomics congress "Proteomics and the Human Proteome: From Bench to Bedside," organized by the Spanish Society of Proteomics and the Latin American Human Proteome Organization (LAHUPO).

Held at the School of Science , the meeting 250 experts from nine countries, including some of the most internationally renowned specialists in this subject.

According to Fernando Corrales, director the Proteomics, Genomics, and Bioinformatics Unit at research center Applied research center (CIMA) at the University of Navarra, this discipline goal proteome, or the set of proteins in a cell, tissue, or organ—will provide a comprehensive view of cellular biology and its alterations, "and with it, to devise new diagnostic methods in the future that enable therapeutic strategies tailored to the needs of each individual," he clarifies.

In this regard, the doctor in Biochemistry Molecular Biology emphasizes that one of the greatest challenges of the 21st century will be, precisely, the identification of biomarkers for the early diagnosis and monitoring of diseases, "which will facilitate more appropriate clinical intervention." With this goal in mind, CIMA Proteomics Unit CIMA projects to analyze the instructions of liver diseases and identify biological markers for liver fibrosis and liver cancer. His work has already resulted in 25 international publications and four patents over the past five years.

Entre los ponentes del Congreso destacan tres de los pioneros de esta disciplina: Peter Roepstorff, Michael Karas y Franz Hillenkamp, a quienes se nombrará miembros honoríficos de la Sociedad Española de Proteómica. Asimismo, el hasta hace unos meses presidente de la Human Proteome Organisation (HUPO), el profesor Rolf Apweiler, y los líderes de la organización en los campos de hígado y cerebro -Fuchu He y Helmut E. Meyer, respectivamente- presentarán en Pamplona los avances más recientes en el estudio del proteoma humano y sus alteraciones asociadas a enfermedades.

meeting, which features the Government of Navarre’s partnership , SODENA, Digna Biotech, and Genoma España, among other organizations, will feature plenary sessions, oral presentations, and an extensive sample of posters highlighting the main research projects currently underway in this area.